Genetic study of inflammatory bowel disease across different populations
Collects blood or saliva samples to study genes in people with inflammatory bowel disease.
Plain-language title generated from the registry record
Registry title: Genome Analysis Across Populations in Inflammatory Bowel Disease
Key facts
- Where
- Toronto, CanadaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-undetermined) and healthy volunteers with no bowel disease history. It studies genetic and environmental factors in IBD.
- Age
- Any age
- Sex
- All sexes can join
- Disease stage
- Diagnosed inflammatory bowel disease: Crohn's disease, ulcerative colitis or IBD-undetermined (IBD-U). Medical records must confirm the diagnosis.
Main reasons for not taking part
- Other gastrointestinal conditions that do not fit the IBD or healthy control groups
- Healthy controls: any personal history of IBD
- Healthy controls: any family history of IBD
- Healthy controls: history of unexplained chronic diarrhea, blood in stool, anemia, abdominal pain or weight loss
Read by machine on 12 November 2026.
Where in Canada
- Sinai Health SystemToronto, CanadaContact: Joanne Stempak, MScTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Mount Sinai Hospital, Canada
- Trial code
- NCT06042387
- Record updated
- 9 October 2026
- Original description
Objective:Read full original descriptionShow less
Genome Analysis Across Populations in Inflammatory Bowel Disease
Objective:
To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.
Inclusion: Subjects: diagnosed with Inflammatory Bowel Disease (Crohn's disease, ulcerative colitis, IBD-undetermined); Available medical records to confirm IBD diagnosis (Crohn's disease, Ulcerative colitis, IBD undetermined (IBD-U)); Healthy controls: no personal history of IBD, no family history of IBD, no history of unexplained chronic diarrhea/blood in stool/anemia/abdominal pain/weight loss; Any age.
Exclusion: Subjects with other gastrointestinal conditions not meeting the above IBD or Healthy Control criteria.